PF-Atlas › Clinical Trials › NCT01747330
Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency
Pancreatin · Phase 3
Registry ID
NCT01747330
Phase
Phase 3
Status
Completed
Drug / intervention
Pancreatin
Sponsor
Abbott Products
Start
2012-06
Enrollment
40
Locations
9
About this trial
The purpose of this study is to evaluate the safety and tolerability of Creon micro in children younger than four years with pancreatic exocrine insufficiency.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01747330 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.